Note: Ingredients listed on restricted chemical lists
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
General Information
Revision date
2023-05-18
Product name
Olanzapine for Injection
Manufacturer Name
Aspiro Pharma Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Hazard Codes
Hazard statements (CLP)
H302, H317, H318
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Hazard statements
May form combustible dust concentrations in air. Harmful if swallowed. May cause an allergic skin reaction. Causes serious eye damage.
Precautionary statements
Avoid breathing vapors, mist, or spray. Wash hands, forearms, and other exposed areas thoroughly after handling. Do not eat, drink or smoke when using this product. Contaminated work clothing must not be allowed out of the workplace. Wear protective gloves, protective clothing, and eye protection. If swallowed: Call a poison center or doctor if you feel unwell. If on skin: Wash with plenty of water If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a poison center or doctor Rinse mouth. If skin irritation or rash occurs: Get medical advice/attention. Take off contaminated clothing and wash it before reuse. Dispose of contents/container in accordance with local, regional, national, and international regulations.
2.3 Other hazards
Exposure may aggravate those with pre-existing eye, skin, or respiratory conditions. Therapeutic use has resulted in the following adverse effects: sleepiness, weight gain, increases in serum prolactin, dizziness, weakness, restlessness, increase appetite, swelling of hands and feet, decreased blood pressure when standing, dry mouth and constipation Overdose of the drug has resulted in changes in heart rate and rhythm, slurred speech, reduced level of consciousness ranging from sedation to coma.